Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V D Steen

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Annals of Internal Medicine|October 18, 2000
Long-term outcomes of scleroderma renal crisisV D Steen, T A Medsger
Annals of Internal Medicine|November 15, 1993
Autoantibody reactive with RNA polymerase III in systemic sclerosisY Okano, V D Steen, T A Medsger
Annals of Internal Medicine|May 1, 1986
The toxicity of D-penicillamine in systemic sclerosisV D Steen, S Blair, T A Medsger
Arthritis and Rheumatism|January 11, 1992
Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosisY Okano, V D Steen, T A Medsger
Annals of Internal Medicine|November 1, 1982
D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysisV D Steen, T A Medsger, G P Rodnan
The Journal of Hand Surgery|May 1, 1996
Compression of the median nerve proximal to the carpal tunnel in sclerodermaC Y Ko, N F Jones, V D Steen
Clinical and Experimental Rheumatology|August 2, 2003
Assessment of kidney involvementV D Steen, M D Mayes, P A Merkel
Arthritis and Rheumatism|February 1, 1988
Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisV D Steen, D L Powell, T A Medsger
Arthritis and Rheumatism|September 1, 1994
Severe restrictive lung disease in systemic sclerosisV D Steen, C Conte, G R Owens, et al.
Archives of Dermatology|September 1, 1988
Cutaneous hypoxia in patients with systemic sclerosis (scleroderma)J L Silverstein, V D Steen, T A Medsger, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Annals of Internal Medicine|October 18, 2000
Long-term outcomes of scleroderma renal crisisV D Steen, T A Medsger
Annals of Internal Medicine|November 15, 1993
Autoantibody reactive with RNA polymerase III in systemic sclerosisY Okano, V D Steen, T A Medsger
Annals of Internal Medicine|May 1, 1986
The toxicity of D-penicillamine in systemic sclerosisV D Steen, S Blair, T A Medsger
Arthritis and Rheumatism|January 11, 1992
Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosisY Okano, V D Steen, T A Medsger
Annals of Internal Medicine|November 1, 1982
D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysisV D Steen, T A Medsger, G P Rodnan
The Journal of Hand Surgery|May 1, 1996
Compression of the median nerve proximal to the carpal tunnel in sclerodermaC Y Ko, N F Jones, V D Steen
Clinical and Experimental Rheumatology|August 2, 2003
Assessment of kidney involvementV D Steen, M D Mayes, P A Merkel
Arthritis and Rheumatism|February 1, 1988
Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisV D Steen, D L Powell, T A Medsger
Arthritis and Rheumatism|September 1, 1994
Severe restrictive lung disease in systemic sclerosisV D Steen, C Conte, G R Owens, et al.
Archives of Dermatology|September 1, 1988
Cutaneous hypoxia in patients with systemic sclerosis (scleroderma)J L Silverstein, V D Steen, T A Medsger, et al.
Pageof 9